NCT04067583View on ClinicalTrials.gov

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

CompletedOBSERVATIONAL
Enrollment

454

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

April 15, 2020

Study Completion Date

April 23, 2020

Conditions
Ophthalmology, Macular Degeneration
Interventions
OTHER

Physician questionnaire

This is a one-time cross-sectional survey of physicians, conducted electronically; there are no in person visits

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY